RecruitingPhase 4NCT06246396

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the Gut Microbiota-brain-immune Axis


Sponsor

University of Florida

Enrollment

120 participants

Start Date

Jan 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn about the mechanisms by which minocycline effect blood pressure in individuals with treatment-resistant hypertension. The main questions it aims to answer are: * To what extent does minocycline lower blood pressure? * Are such blood pressure effects mediated through changes in gut microbiota, gut leakiness, systemic inflammation, neuroinflammation, or some combination of these? Participants will be randomly assigned to treatment with minocycline or placebo, treated daily for 3 months, to evaluate these questions.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether the antibiotic minocycline can lower blood pressure in people with treatment-resistant hypertension — meaning their blood pressure stays high despite taking three or more blood pressure medications. Researchers think minocycline may work by reducing inflammation in the brain and kidneys that contributes to persistent high blood pressure. **You may be eligible if...** - You are 18 or older - Your blood pressure remains uncontrolled (high on 24-hour monitoring) despite being on 3 or more blood pressure medications, including a diuretic (water pill) - You have been on a stable medication regimen for at least 2 weeks - You are willing to have study procedures performed **You may NOT be eligible if...** - You have a known allergy or intolerance to minocycline or other tetracycline antibiotics - You have taken or plan to take oral antibiotics recently (within 3 months) - Your kidney function is significantly impaired (eGFR below 45) - Your high blood pressure is caused by an identifiable underlying condition (secondary hypertension) - You have had a hospitalization for hypertensive crisis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMinocycline Hydrochloride

Minocycline Hydrochloride 100 mg twice daily

DRUGPlacebo

Placebo


Locations(1)

UF Clinical Research Center (UF CRC) - CTSI

Gainesville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06246396


Related Trials